EMEA-000883-PIP01-10-M05 - paediatric investigation plan
Treosulfan
PIPHuman
medac Gesellschaft für klinische Spezialpräparate mbH
Germany
Tel. +49 (0) 401380060
E-mail: dra@medac.de
P/0346/2020: EMA decision of 9 September 2020 on the acceptance of a modification of an agreed paediatric investigation plan for treosulfan (Trecondi), (EMEA-000883-PIP01-10-M05)